Fan Xia

Fan Xia

Auto-generated profile, based on publicly available information

Fan Xia

Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2022 in Science Advances
Verified
Journal Article
Open access
FXFan Xia
Fan Xia
Yuan MaYuan Ma
Yuan Ma
Kangfu ChenKangfu Chen
Kangfu Chen
BDBill Duong
Bill Duong
SASharif Ahmed
Sharif Ahmed
SKShana O. Kelley
Shana O. Kelley
Circulating tumor cells (CTCs) break free from primary tumors and travel through the circulation system to seed metastatic tumors, which are the major cause of death from cancer. The identification of the major genetic factors that enhance production and persistence of CTCs in the bloodstream at a whole genome level would enable more comprehensive molecular mechanisms of metastasis to be elucidated and the identification of novel therapeutic targets, but this remains a challenging task due to the heterogeneity and extreme rarity of CTCs. Here, we describe an in vivo genome-wide CRISPR knockout screen using CTCs directly isolated from a mouse xenograft. This screen elucidated SLIT2 —a gene encoding a secreted protein acting as a cellular migration cue—as the most significantly represented gene knockout in the CTC population. SLIT2 knockout cells are highly metastatic with hypermigratory and mesenchymal phenotype, resulting in enhanced cancer progression in xenograft models.

21 August 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
FXFan Xia
Fan Xia
YMYuan Ma
Yuan Ma
KCKangfu Chen
Kangfu Chen
BDBill Duong
Bill Duong
SASharif Ahmed
Sharif Ahmed
SKShana O. Kelley
Shana O. Kelley
Circulating tumor cells (CTCs) break free from primary tumors and travel through the bloodstream and lymphatic system to seed metastatic tumors, which are the major cause of death from cancer. The identification of the major genetic factors that enhance production and persistence of CTCs in the bloodstream at a whole genome level would enable more comprehensive molecular mechanisms of metastasis to be elucidated and the identification of novel therapeutic targets, but this remains a challenging task due to the heterogeneity and extreme rarity of CTCs. Here, we describe the first in vivo genome-wide CRISPR KO screen using CTCs directly isolated from a mouse xenograft. This screen elucidated SLIT2 – a gene encoding a secreted protein acting as a cellular migration cue – as the most significantly represented gene knockout in the CTC population. SLIT2 knockout cells are highly metastatic with hypermigratory and mesenchymal phenotype. Reduced expression of SLIT2 is observed in human tumors, indicating its role as a negative modulator of tumor progression and metastasis.